Your browser doesn't support javascript.
loading
Injection anxiety and pain in men using intracavernosal injection therapy after radical pelvic surgery.
Nelson, Christian J; Hsiao, Wayland; Balk, Eliana; Narus, Joseph; Tal, Raanan; Bennett, Nelson E; Mulhall, John P.
Affiliation
  • Nelson CJ; Department of Psychiatry and Behavioral Sciences, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
J Sex Med ; 10(10): 2559-65, 2013 Oct.
Article in En | MEDLINE | ID: mdl-23898886
ABSTRACT

INTRODUCTION:

Intracavernosal injection (ICI) therapy is a well-recognized treatment strategy with high success rates for men with erectile dysfunction. Despite this, injection anxiety and pain related to injection are significant barriers to its use.

AIMS:

This study aims to examine injection anxiety and injection pain in patients using ICI.

METHODS:

Men starting ICI therapy post radical pelvic surgery completed questionnaires at initial visit, at each of the two ICI training sessions and at a 4-month follow-up visit. MAIN OUTCOME

MEASURES:

Injection Anxiety Scale, Injection Pain Scale, Injection Reaction Inventory, and the Erectile Function Domain of the International Index of Erectile Function.

RESULTS:

Average age of the 68 men was 60±8 years. At 4 months, the self-reported frequency of ICI use was 29%<1/week, 26% 1/week, 40% 2/week, and 5% 3/week. Mean injection anxiety score at first injection was 5.7±2.8 (range 0-10) and significantly decreased to a 4.1±3 at 4 months (P<0.001). At first injection, 65% reported high injection anxiety (≥5) and this significantly decreased to 42% (P=0.003) at 4 months. Anxiety at first injection was negatively related to ICI frequency at 4 months (r=-0.23, P=0.08). Mean injection pain score at first injection was low (2.2±1.8, range 0-10) and 59% rated injection pain≤2. Injection pain remained consistent across time periods. At first injection, injection anxiety (assessed prior to injection) was related to injection pain (r=0.21, P=0.04) and subjects (n=21) who reported high injection anxiety (≥5) across time points, reported an increase in injection pain scores from first injection to 4 months (2.7 vs. 3.7, P=0.05).

CONCLUSIONS:

Although injection anxiety decreased with ICI use, mean injection anxiety remained at a moderate level (4.4) and 42% of men continued to report "high" injection anxiety at 4 months. While injection pain was low, injection anxiety and pain were related. These data suggest the need for a psychological intervention to help lower injection anxiety related to ICI.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Anxiety / Pain / Urologic Surgical Procedures, Male / Vasodilator Agents / Penile Erection / Self Administration / Erectile Dysfunction Type of study: Diagnostic_studies / Etiology_studies Limits: Aged / Humans / Male / Middle aged Language: En Year: 2013 Type: Article

Full text: 1 Database: MEDLINE Main subject: Anxiety / Pain / Urologic Surgical Procedures, Male / Vasodilator Agents / Penile Erection / Self Administration / Erectile Dysfunction Type of study: Diagnostic_studies / Etiology_studies Limits: Aged / Humans / Male / Middle aged Language: En Year: 2013 Type: Article